Multiplexed Cas9 targeting reveals genomic location effects and gRNA-based staggered breaks influencing mutation efficiency
Santiago Gisler (Nederlands Kanker Instituut - Antoni van Leeuwenhoek ziekenhuis)
Joana P. Gonçalves (Nederlands Kanker Instituut - Antoni van Leeuwenhoek ziekenhuis, TU Delft - Pattern Recognition and Bioinformatics)
Waseem Akhtar (Nederlands Kanker Instituut - Antoni van Leeuwenhoek ziekenhuis)
Johann de Jong (UCB Biosciences GmbH, Nederlands Kanker Instituut - Antoni van Leeuwenhoek ziekenhuis)
Alexey V. Pindyurin (Nederlands Kanker Instituut - Antoni van Leeuwenhoek ziekenhuis, Russian Academy of Sciences)
Lodewyk F.A. Wessels (TU Delft - Pattern Recognition and Bioinformatics, Nederlands Kanker Instituut - Antoni van Leeuwenhoek ziekenhuis)
Maarten van Lohuizen (Nederlands Kanker Instituut - Antoni van Leeuwenhoek ziekenhuis)
More Info
expand_more
Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.
Abstract
Understanding the impact of guide RNA (gRNA) and genomic locus on CRISPR-Cas9 activity is crucial to design effective gene editing assays. However, it is challenging to profile Cas9 activity in the endogenous cellular environment. Here we leverage our TRIP technology to integrate ~ 1k barcoded reporter genes in the genomes of mouse embryonic stem cells. We target the integrated reporters (IRs) using RNA-guided Cas9 and characterize induced mutations by sequencing. We report that gRNA-sequence and IR locus explain most variation in mutation efficiency. Predominant insertions of a gRNA-specific nucleotide are consistent with template-dependent repair of staggered DNA ends with 1-bp 5′ overhangs. We confirm that such staggered ends are induced by Cas9 in mouse pre-B cells. To explain observed insertions, we propose a model generating primarily blunt and occasionally staggered DNA ends. Mutation patterns indicate that gRNA-sequence controls the fraction of staggered ends, which could be used to optimize Cas9-based insertion efficiency.
help_outline